Plain-English translation of NCT06309966 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This research study is testing a new medication called to see if it can help people whose focal seizures (seizures that start in one part of the brain) have not been controlled by other anti-seizure drugs. The trial will compare two different doses of this medication against a placebo (a dummy pill with no active drug) to determine which works best and is safest for patients.
Many people with focal epilepsy continue to have seizures even after trying multiple anti-seizure medications. This trial exists to find out whether this medication offers a new treatment option for people whose seizures are hard to control with current available drugs.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to take either one of two doses of the new medication or a placebo pill. You'll visit the study clinic multiple times to have your health checked, discuss your seizures, and have blood tests or other monitoring done. Throughout the trial, you'll keep a diary of your seizures to help the researchers track how well the treatment is working.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States